`
`Document:61
`
`Page:1_
`
`Filed: 07/09/2024
`
`NOTE: This order is nonprecedential.
`
`GAnited States Court of Appeals
`for the Federal Circuit
`
`REGENERON PHARMACEUTICALS,INC.,
`Appellant
`
`Vv.
`
`MYLAN PHARMACEUTICALSINC., CELLTRION,
`INC., APOTEX INC.,
`Appellees
`
`2023-1395, 2023-1396
`
`Appeals from the United States Patent and Trademark
`Office, Patent Trial and Appeal Board in Nos. IPR2021-
`00880, IPR2021-00881, IPR2022-00257, IPR2022-00258,
`IPR2022-00298, IPR2022-00301.
`
`ORDER
`
`The parties, having so agreed,
`
`IT IS ORDERED THAT:
`
`The above-captioned appeals are dismissed under Fed.
`R. App. P. 42(b) with each side to bear their own costs.
`
`FOR THE COURT
`
`
`
`Jarrett B. Perlow
`July
`9, 2024
`Clerk of Court
`YULYJ,4U24
`Date
`
`ISSUED AS A MANDATE:July 9, 2024
`
`